SELL Indus Towers — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred Intraday)28 Jul 2026, 5:30 am ISTvia Economic Times New Stock Recos
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Indus Towers shares in focus after higher provisions impact profit, margins in Q1
NewsCnbc-Tv18·28 Jul · today
Q1 Results Today Highlights: BEL & Canara Bank Q1 PAT up, P N Gadgil PAT jumps 51%, HUDCO & TMB profit rise, Coal India, Tata Power, Indus Towers, Coforge, Godfrey Phillips to announce Q1 results
NewsHbl·27 Jul · today
Indus Towers Q1 Results: Profit Flat As Margins Narrow; Revenue Up 5%
NewsNdtv-Profit·27 Jul · today
Indus Towers Ltd announced its audited consolidated financial results for the first quarter ended June 30, 2026. The company reported consolidated revenues of Rs. 8,431 Crores, up 4.6% YoY, and consol
BSE · Company Update·27 Jul · today
Indus Towers Limited has informed the Exchange regarding Audited Financial Results for the First Quarter (Q1) ended June 30, 2026.
BSE · Board Meeting·27 Jul · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Indus Towers
- BUY — Ansh Jogendra Bhilwar9 Oct 2026 · ~2 weeks · target ₹385 · Target hit
- BUY — Ansh Jogendra Bhilwar7 Oct 2026 · Same day · target ₹410 · Expired
- BUY — Osho Krishan, Angel One6 Oct 2026 · ~3 months · target ₹400 · Active
- BUY — Rakesh Bansal6 Oct 2026 · ~2 weeks · target ₹400 · SL hit
- BUY — Elara Capital6 Oct 2026 · ~1 year · target ₹495 · Active
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active

